Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
University of California, San Francisco
University of California, San Francisco
Thomas Jefferson University
The First Affiliated Hospital of Soochow University
Shenzhen Second People's Hospital
University of Miami
University of Southern California
Centro Hospitalar Nordeste
Case Comprehensive Cancer Center